Same Indication

Ipilimumab vs Samarium Sm 153 Lexidronam Pentasodium

Ipilimumab vs Samarium Sm 153 Lexidronam Pentasodium: Overview

This comparison examines the pharmacological differences between Ipilimumab and Samarium Sm 153 Lexidronam Pentasodium.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days.

Chemical Properties

Type: Ipilimumab β€” Antibody; Samarium Sm 153 Lexidronam Pentasodium β€” Small molecule.